AgeX Therapeutics Inc (DELISTED) (AGE:DL)
11.10
-1.50
(-11.90%)
USD |
NYAM |
Mar 26, 16:00
12.18
+1.08
(+9.73%)
After-Hours: 20:00
AgeX Therapeutics Free Cash Flow (Quarterly): -1.864M for Sept. 30, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -1.864M |
| June 30, 2023 | -2.019M |
| March 31, 2023 | -1.865M |
| December 31, 2022 | -1.321M |
| September 30, 2022 | -1.236M |
| June 30, 2022 | -1.746M |
| March 31, 2022 | -1.636M |
| December 31, 2021 | -1.647M |
| September 30, 2021 | -1.884M |
| June 30, 2021 | -1.694M |
| March 31, 2021 | -2.63M |
| December 31, 2020 | -1.62M |
| Date | Value |
|---|---|
| September 30, 2020 | -1.901M |
| June 30, 2020 | -2.248M |
| March 31, 2020 | -2.068M |
| December 31, 2019 | -2.706M |
| September 30, 2019 | -2.609M |
| June 30, 2019 | -2.865M |
| March 31, 2019 | -2.621M |
| December 31, 2018 | -2.046M |
| September 30, 2018 | -2.863M |
| June 30, 2018 | -2.173M |
| March 31, 2018 | -2.806M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-2.865M
Minimum
Jun 2019
-1.236M
Maximum
Sep 2022
-1.976M
Average
-1.874M
Median
Free Cash Flow (Quarterly) Benchmarks
| Homology Medicines Inc (DELISTED) | -21.58M |
| NovaBay Pharmaceuticals Inc | -1.574M |
| Palatin Technologies Inc | -8.607M |
| iBio Inc | -3.654M |
| Theriva Biologics Inc | -4.881M |